The DP™ Plan for Neurodegenerative Conditions & Diseases That Are Not ALS

​The Deanna Protocol® Metabolic Plan (also known as the DP™ Plan) was developed for ALS, originally, but there is a strong possibility that it could work for other conditions such as stroke, traumatic brain injury, concussion, Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and more. Current treatments for these conditions are effective to an extent, but not sufficient.

The Common Denominator For ALS, Alzheimer's Parkinson's, TBI, Concussion & More

Dr. Tedone and the scientists studying the DP™ Plan hypothesize that it could likely be extremely effective when added to current treatments for Alzheimer’s, Parkinson’s, Multiple Sclerosis, strokes, concussions and brain injuries. These conditions above are all different from one another, but there is one common denominator. In all of these conditions, nerve cells die and the damage (cell death) spreads from the initial area of impact to other areas. Cell death spreads because of glutamate.

​Excess Glutamate, ALS, and Cell Death

Why is glutamate the probable culprit? When cells die, they burst and release all of their contents into the space around them. Among these contents is glutamate. There is much more glutamate inside nerve cells than there is outside of it (the ratio is 10,000:1). Cells (nerve cells included) are extremely sensitive to the ratio glutamate inside the cell to outside the cell. When the ratio is incorrect, this can kill the cells. That is what happens here. When a nerve cell dies, all of the glutamate inside it spills out into the area around it and comes into contact with other healthy cells. When the healthy cells come into contact with too much glutamate on the outside, their glutamate ratios are changed dramatically and they die as well. They release more glutamate when they die, which kills more neighboring nerve cells, and so on. Cell death spreads exponentially.

The process above is most likely how the diseases above spread throughout the body. This is also most likely how damage spreads in the brain after strokes, traumatic brain injuries, and concussions. This has already been proven in traumatic brain injuries. (See the evidence in article by The Dana Foundation.) the DP™ Plan delivers substances to the damages nerve cells that enable these cells to produce enough energy to stay alive, despite the fact that they have been poisoned with excess glutamate. ​

Further Research

​There are still many questions left unanswered about the DP™ Plan. Caretakers of those with Alzheimer's have reported that it dramatically reversed the disease and restored cognitive and motor abilities that had been gone for years. While this anecdotal evidence is extremely encouraging, more work needs to be done to understand these results and test them on additional individuals with Alzheimer's disease.

​While we have proven that the DP™ Plan helps in ALS, it certainly is not perfect. This is why we at Winning the Fight continue scientific research. Our research goals for the future include a variety of studies designed to optimize the DP™ Plan in animals, studies on the DP™ Plan’s effectiveness in human nerve cells, and human clinical trials, all in relation to ALS. We also plan to begin researching the DP™ Plan and its effectiveness in the conditions mentioned above. Should our research prove that the DP™ Plan is effective in these conditions, we plan to customize it to fit each disease and condition. Click here if you are interested in supporting our cause.

Current Treatments Available Alzheimer’s, Parkinson’s, and Multiple Sclerosis Are Poor - We Have To Do Better!

​Today, treatments available for Alzheimer’s, Parkinson’s, and Multiple Sclerosis leave much to be desired. Some mask symptoms, but do not slow progression, while others slow progression at the cost of dangerous side effects.

For Alzheimer'sAccording to the Alzheimer’s Association, treatments for Alzheimer’s focus on masking the symptoms of the disease, but do not treat Alzheimer’s disease itself or delay its progression.For Parkinson'sParkinson’s Disease treatments available today, according to Mayo Clinic and the National Institute of Health, focus on increasing dopamine (which is lacking in Parkinson’s) or substituting other substances for dopamine. This works in the beginning stages, but the effectiveness and consistency of Parkinson’s treatments declines as the disease advances. Also, the medications can bring very unpleasant side effects (such as nausea, hallucinations, and behavioral changes).

For Multiple SclerosisWith Multiple Sclerosis, treatments mostly focus on speeding the recovery from attacks and managing symptoms. Mayo Clinic claims that no treatments for Multiple Sclerosis have been shown to slow the progression of primary-progressive MS. For relapsing-remitting Multiple Sclerosis, treatments are available to lower the relapse rate and slow the formation of new lesions in the brain. However, these treatments carry significant health risks.

Current Treatments For Stroke, Concussion, and Traumatic Brain Injury Aren't Good Enough Either!

For StrokesFor strokes and traumatic brain injuries, the treatments used today focus on reducing damage to the brain. However, in order to have positive impact, these treatments must be administered very soon after the incident occurs. The Mayo clinic asserts that stroke treatments used today involve reducing brain damage by reducing pressure in the brain, restoring blood flow to the brain, and preventing further strokes. This is often followed by therapy. ​For TBI & ConcussionsFor traumatic brain injuries, treatments include medications that limit secondary damage to the brain immediately after the injury occurs. Treatments for very severe traumatic brain injuries include major surgery to soon after the injury occurs. For more mild head traumas, such as concussions, the treatment is mental rest, which can be prescribed for an extended period of time, depending on the patient’s symptoms.